{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:11:09Z","timestamp":1783969869079,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507500"],"award-info":[{"award-number":["2023YFC2507500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.arcmed.2025.103304","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T14:39:16Z","timestamp":1757083156000},"page":"103304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Probiotics for the Management of Liver Cirrhosis and Its Complications"],"prefix":"10.1016","volume":"56","author":[{"given":"Junxiu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-8048","authenticated-orcid":false,"given":"Nahum","family":"M\u00e9ndez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-6739","authenticated-orcid":false,"given":"Xingshun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103304_bib0001","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis - aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0002","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.arcmed.2025.103304_bib0003","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s12325-023-02430-3","article-title":"Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses","volume":"40","author":"Zheng","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.arcmed.2025.103304_bib0004","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00018-018-2943-4","article-title":"An insight into gut microbiota and its functionalities","volume":"76","author":"Adak","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.arcmed.2025.103304_bib0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.arcmed.2025.103304_bib0006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2025.103304_bib0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3892\/ijmm.2021.5016","article-title":"Dysbiosis and liver diseases (Review)","volume":"48","author":"Nishikawa","year":"2021","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.arcmed.2025.103304_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut microbes"},{"key":"10.1016\/j.arcmed.2025.103304_bib0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2025.103304_bib0011","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0012","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1443-9573.2004.00157.x","article-title":"Intestinal microflora in patients with liver cirrhosis","volume":"5","author":"Zhao","year":"2004","journal-title":"Chin J Dig Dis"},{"key":"10.1016\/j.arcmed.2025.103304_bib0013","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2025.103304_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1218552","article-title":"Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis","volume":"13","author":"Wu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0016","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MCG.0000000000002002","article-title":"World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics","volume":"58","author":"Guarner","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0017","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/liv.13005","article-title":"Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials","volume":"36","author":"Saab","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hbpd.2018.01.005","article-title":"Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis","volume":"17","author":"Cao","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0019","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.clinre.2015.03.008","article-title":"Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis","volume":"39","author":"Zhao","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jff.2015.05.009","article-title":"Current evidence on the use of probiotics in liver diseases","volume":"17","author":"Ch\u00e1vez-Tapia","year":"2015","journal-title":"J Funct Foods"},{"key":"10.1016\/j.arcmed.2025.103304_bib0021","article-title":"Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials","volume":"11","author":"Yang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2025.103304_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176874","article-title":"Efficacy of probiotics on improvement of health outcomes in cirrhotic liver disease patients: A systematic review and meta-analysis of randomised controlled trials","volume":"981","author":"Leitner","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0023","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032335","article-title":"Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis","volume":"101","author":"Huang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcmed.2025.103304_bib0024","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/apt.12695","article-title":"Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis","volume":"39","author":"Bajaj","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2025.103304_bib0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.clnu.2019.04.004","article-title":"Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials","volume":"39","author":"Kazemi","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.arcmed.2025.103304_bib0026","article-title":"Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis","volume":"18","author":"Xia","year":"2023","journal-title":"Open Life Sci"},{"key":"10.1016\/j.arcmed.2025.103304_bib0027","first-page":"558","article-title":"Probi\u00f3ticos en las enfermedades hep\u00e1ticas","volume":"28","author":"Soriano","year":"2013","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.arcmed.2025.103304_bib0038","article-title":"Antibiotics and probiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and a meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"PloS one"},{"key":"10.1016\/j.arcmed.2025.103304_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102361","article-title":"Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis","volume":"48","author":"Chang","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0045","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1111\/liv.16081","article-title":"Meta-analysis of probiotics efficacy in the treatment of minimum hepatic encephalopathy","volume":"44","author":"Zhou","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0070","first-page":"991","article-title":"Meta analysis of probiotics in prevention of spontaneous bacterial peritonitis in patients with cirrhosis","volume":"36","author":"Zheng","year":"2015","journal-title":"Acad J Chin PLA Med Sch"},{"key":"10.1016\/j.arcmed.2025.103304_bib0028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"de Franchis","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2025.103304_bib0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0031","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/liv.12598","article-title":"Breaking bad - the two sides of gut microbiota in portal hypertension","volume":"34","author":"Mehta","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0032","doi-asserted-by":"crossref","first-page":"e7521","DOI":"10.5812\/hepatmon.7521","article-title":"Probiotic as a novel treatment strategy against liver disease","volume":"13","author":"Imani Fooladi","year":"2013","journal-title":"Hepat Mon."},{"key":"10.1016\/j.arcmed.2025.103304_bib0033","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1478-3231.2009.02020.x","article-title":"Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study","volume":"29","author":"Tandon","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0034","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/liv.12280","article-title":"VSL#3 (R) probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis","volume":"33","author":"Jayakumar","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0035","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.4254\/wjh.v14.i8.1667","article-title":"Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial","volume":"14","author":"Maslennikov","year":"2022","journal-title":"World J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0036","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/liv.12539","article-title":"Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites","volume":"34","author":"Rincon","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0037","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0047","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MEG.0000000000002567","article-title":"Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment","volume":"35","author":"Shi","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0067","first-page":"49","article-title":"Clinical efficacy of Bacillus licheniformis in treatment of spontaneous bacterial peritonitis in patients with liver cirrhosis","volume":"24","author":"Cai","year":"2012","journal-title":"Chin J Microecol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0068","first-page":"931","article-title":"Effect of meropenem combined with probiotics in the treatment of patients with cirrhosis complicated with spontaneous bacterial peritonitis","volume":"45","author":"Wang","year":"2024","journal-title":"World Clin Drugs"},{"key":"10.1016\/j.arcmed.2025.103304_bib0072","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/liv.12172","article-title":"Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial","volume":"33","author":"Gupta","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0073","first-page":"331","article-title":"Role of probiotics in primary prevention of esophagogastric variceal bleeding","volume":"37","author":"Zhang","year":"2021","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0075","article-title":"Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy","volume":"26","author":"Zhang","year":"2020","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.arcmed.2025.103304_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/gutjnl-2025-IDDF.147","article-title":"Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024)","volume":"13","author":"Xu","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0041","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cld.2020.01.001","article-title":"Epidemiology of Hepatic Encephalopathy","volume":"24","author":"Elsaid","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.arcmed.2025.103304_bib0042","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0043","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41591-024-03405-9","article-title":"The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis","volume":"31","author":"He","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2025.103304_bib0044","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.3390\/ijms23168999","article-title":"The Link between Gut Microbiota and Hepatic Encephalopathy","volume":"23","author":"Won","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103304_bib0046","article-title":"Probiotics for people with hepatic encephalopathy","volume":"2","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcmed.2025.103304_bib0048","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.3748\/wjg.v25.i36.5403","article-title":"Chinese guidelines on management of hepatic encephalopathy in cirrhosis","volume":"25","author":"Xu","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0049","first-page":"156","article-title":"The Mexican consensus on probiotics in gastroenterology","volume":"82","author":"Valdovinos","year":"2017","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.arcmed.2025.103304_bib0050","first-page":"13","article-title":"Update on the Complications and Management of Liver Cirrhosis","volume":"13","author":"Fadlallah","year":"2025","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.arcmed.2025.103304_bib0051","first-page":"813","article-title":"Guidelines on the management of ascites in cirrhosis (2023 version)","volume":"31","year":"2023","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.arcmed.2025.103304_bib0052","article-title":"Recent insights into contributing factors in the pathogenesis of cirrhotic ascites","volume":"11","author":"Li","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2025.103304_bib0053","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.3748\/wjg.v25.i28.3738","article-title":"Current approaches to the management of patients with cirrhotic ascites","volume":"25","author":"Garbuzenko","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0054","first-page":"1481","article-title":"Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis","volume":"22","author":"Zhang","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2025.103304_bib0055","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0056","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/ijms22010199","article-title":"The Role of the Gut Microbiome in Liver Cirrhosis Treatment","volume":"22","author":"Lee","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103304_bib0057","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/liv.12566","article-title":"VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis","volume":"35","author":"S\u00e1nchez","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103304_bib0058","doi-asserted-by":"crossref","DOI":"10.1038\/srep45712","article-title":"Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride","volume":"7","author":"S\u00e1nchez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2025.103304_bib0059","first-page":"9996","article-title":"Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats","volume":"8","author":"Jiang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.arcmed.2025.103304_bib0060","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3748\/wjg.v19.i25.4053","article-title":"Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites","volume":"19","author":"Liu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0061","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/jmf.2023.K.0129","article-title":"Probiotics-A Promising Novel Therapeutic Approach in the Management of Chronic Liver Diseases","volume":"27","author":"Ramachandran","year":"2024","journal-title":"J Med Food"},{"key":"10.1016\/j.arcmed.2025.103304_bib0062","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S0037-86822003000600012","article-title":"Spontaneous bacterial peritonitis","volume":"36","author":"Strauss","year":"2003","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1016\/j.arcmed.2025.103304_bib0063","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jceh.2018.08.006","article-title":"Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis","volume":"9","author":"Ghosh","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0064","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0168-8278(02)00142-3","article-title":"Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis","volume":"37","author":"Chiva","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103304_bib0066","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/apt.13788","article-title":"Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis","volume":"44","author":"Horvath","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2025.103304_bib0069","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s40001-025-02712-2","article-title":"Effect of freeze-dried powder of lactic acid bacteria treatment of pediatric bacterial peritonitis on immune function and nutritional status","volume":"30","author":"Xue","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.arcmed.2025.103304_bib0071","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1503\/cmaj.051700","article-title":"Current management of the complications of portal hypertension: variceal bleeding and ascites","volume":"174","author":"Dib","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.arcmed.2025.103304_bib0074","first-page":"4752","article-title":"Effect of Enteric Probiotics Combined with Octreotide on Hemodynamics and Prognosis in Patients with Cirrhosis Combined with Gastroesophageal Varicosity Primary Hemorrhage","volume":"18","author":"Dong","year":"2018","journal-title":"Prog Mod Biomed"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:20:52Z","timestamp":1765617652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440925001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0188440925001249"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103304","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probiotics for the Management of Liver Cirrhosis and Its Complications","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103304"}}